JP2024505517A5 - - Google Patents

Info

Publication number
JP2024505517A5
JP2024505517A5 JP2023545783A JP2023545783A JP2024505517A5 JP 2024505517 A5 JP2024505517 A5 JP 2024505517A5 JP 2023545783 A JP2023545783 A JP 2023545783A JP 2023545783 A JP2023545783 A JP 2023545783A JP 2024505517 A5 JP2024505517 A5 JP 2024505517A5
Authority
JP
Japan
Prior art keywords
approximately
formulation
formulation according
pilocarpine
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023545783A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024505517A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/014317 external-priority patent/WO2022165178A1/en
Publication of JP2024505517A publication Critical patent/JP2024505517A/ja
Publication of JP2024505517A5 publication Critical patent/JP2024505517A5/ja
Pending legal-status Critical Current

Links

JP2023545783A 2021-01-28 2022-01-28 製剤 Pending JP2024505517A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163142889P 2021-01-28 2021-01-28
US63/142,889 2021-01-28
PCT/US2022/014317 WO2022165178A1 (en) 2021-01-28 2022-01-28 Formulations

Publications (2)

Publication Number Publication Date
JP2024505517A JP2024505517A (ja) 2024-02-06
JP2024505517A5 true JP2024505517A5 (cg-RX-API-DMAC7.html) 2025-01-16

Family

ID=82494246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023545783A Pending JP2024505517A (ja) 2021-01-28 2022-01-28 製剤

Country Status (6)

Country Link
US (3) US11872213B2 (cg-RX-API-DMAC7.html)
EP (1) EP4284362A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024505517A (cg-RX-API-DMAC7.html)
AU (1) AU2022212108A1 (cg-RX-API-DMAC7.html)
CA (1) CA3210064A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022165178A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220160668A1 (en) 2020-11-23 2022-05-26 Sight Sciences, Inc. Formulations and methods for treating conditions of the eye
US11872213B2 (en) 2021-01-28 2024-01-16 Glaukos Corporation Formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
ES2752008T3 (es) * 2009-10-30 2020-04-02 Intratus Inc Métodos y composiciones para la liberación sostenida de fármacos
US9421199B2 (en) * 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US11052094B2 (en) * 2015-05-29 2021-07-06 Sydnexis, Inc. D2O stabilized pharmaceutical formulations
US20190262290A1 (en) * 2016-10-12 2019-08-29 Ps Therapies Ltd Drug vehicle compositions and methods of use thereof
CN110996904A (zh) * 2017-05-19 2020-04-10 奥古根有限公司 眼用组合物及使用方法
JP6946575B2 (ja) * 2018-04-24 2021-10-06 アラーガン、インコーポレイテッドAllergan,Incorporated 眼の状態の治療のためのピロカルピン塩酸塩の使用
US11872213B2 (en) 2021-01-28 2024-01-16 Glaukos Corporation Formulations
WO2024026365A1 (en) * 2022-07-26 2024-02-01 Glaukos Corporation Ophthalmic topical cream formulations and uses thereof

Similar Documents

Publication Publication Date Title
JP7224390B2 (ja) アトロピン含有水性組成物
CN102046149B (zh) 稳定的眼药制剂
BRPI0607447B1 (pt) Composição oftálmica de bimatoprosta aprimorada
TW201204390A (en) Novel ophthalmic compositions
JP2002332248A (ja) Gリッチなアルギン酸含有組成物
JP2014515383A (ja) PGF2α類似体を含む眼科用製剤
JP3974431B2 (ja) アルギン酸含有組成物
KR102638866B1 (ko) 사이클로스포린 및 멘톨 함유 나노 에멀젼 점안 조성물 및 그의 제조 방법
JPWO2001087304A1 (ja) 点眼剤
US20220233506A1 (en) Formulations
CA2851492A1 (en) Ophthalmic gel compositions
JP2002114711A (ja) 外用剤組成物
CN110022856B (zh) 用于降低眼压的眼用组合物
TW200927169A (en) Complement Clq inhibitors for the prevention and treatment of glaucoma
JP2005008596A (ja) 眼科用組成物
CN103732224B (zh) 用于眼睫毛生长的组合物
JPH01294633A (ja) 点眼剤
JPH11130675A (ja) クロマン誘導体含有点眼液
JP2006348055A (ja) アルギン酸含有組成物
JP5999875B2 (ja) ゲル状医薬組成物
US20230310429A1 (en) Formulations for reducing hair loss and/or increasing hair regrowth
HK40005358B (en) Eye-drop composition for lowering intraocular pressure
JP2010077160A (ja) 眼科用組成物
HK40005358A (en) Eye-drop composition for lowering intraocular pressure